Argenx (ARGX) Financial Analysis & Valuation | Quarter Chart

Argenx (ARGX)

ARGX
Price: $806.46
Fair Value: 🔒
🔒score
argenx SE, a biotechnology company, engages in the developing of various therapies for the treatment of autoimmune diseases in the United States, Japan, Europe, Middle East, Africa, and China. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thr... more
argenx SE, a biotechnology company, engages in the developing of various therapies for the treatment... more
Description Shares
Market Cap$49.91BExchangeNASDAQ
SectorHealthcareIndustryBiotechnology
CountryNLCEOTimothy Van Hauwermeiren
IPO Date2017-05-18CAGR0.77%
Employees1,599Websitewww.argenx.com
Div. Yield—Payout Ratio—
Buy Back Yield0.04%Total Yield0.04%
ARGX chart loading...
Fundamentals Technicals
Enterprise Value$48.24BP/E Ratio35.86
Forward P/E25.45PEG Ratio0.31
P/S Ratio14.91P/B Ratio6.82
P/CF Ratio66.76P/FCF Ratio67.79
EPS$22.53EPS Growth 1Y—
EPS Growth 3Y—EPS Growth 5Y—
Revenue Growth 1Y139.04%Gross Margin0.89%
Operating Margin0.26%Profit Margin0.33%
ROE0.17%ROA0.13%
ROCE0.12%Current Ratio5.23
Quick Ratio4.87Cash Ratio2.64
Debt/Equity0.01Interest Coverage292.59
Altman Z Score23.97Piotroski Score5

View Argenx financial charts →